Insider Transactions in Q1 2022 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2022
|
Lynne Chou O'Keefe Director |
SELL
Open market or private sale
|
Direct |
10,044
-100.0%
|
$40,176
$4.5 P/Share
|
|
Mar 15
2022
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,958
-8.24%
|
$87,832
$4.34 P/Share
|
|
Mar 15
2022
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,211
+13.4%
|
-
|
|
Mar 15
2022
|
Kristen Green Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+50.0%
|
-
|
|
Mar 15
2022
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+50.0%
|
-
|
|
Mar 15
2022
|
Ambar Bhattacharyya Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,121
+26.32%
|
-
|
|
Mar 15
2022
|
Garcia Andrea G Perez Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,121
+50.0%
|
-
|
|
Mar 15
2022
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,248
-21.06%
|
$20,992
$4.34 P/Share
|
|
Mar 15
2022
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,913
+35.83%
|
-
|
|
Mar 15
2022
|
Delos M. Cosgrove Director |
BUY
Exercise of conversion of derivative security
|
Direct |
564
+9.99%
|
-
|
|
Mar 15
2022
|
David B Wells Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,044
+2.39%
|
-
|
|
Mar 15
2022
|
Melissa Baird Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,920
-1.47%
|
$23,680
$4.34 P/Share
|
|
Mar 15
2022
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,344
+5.71%
|
-
|
|
Mar 15
2022
|
Alex Bard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+50.0%
|
-
|
|
Mar 15
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,487
-1.03%
|
$13,948
$4.34 P/Share
|
|
Mar 15
2022
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,089
+2.89%
|
-
|
|
Mar 15
2022
|
Jules A. Maltz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,794
+34.01%
|
-
|
|
Mar 14
2022
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
120,059
+24.12%
|
$0
$0.4 P/Share
|
|
Mar 02
2022
|
Lynne Chou O'Keefe Director |
SELL
Open market or private sale
|
Direct |
40,178
-100.0%
|
$200,890
$5.04 P/Share
|
|
Mar 01
2022
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
14,585
-57.0%
|
$72,925
$5.25 P/Share
|
|
Mar 01
2022
|
Lynne Chou O'Keefe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
40,178
+50.0%
|
-
|
|
Feb 28
2022
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
86,820
-41.24%
|
$434,100
$5.17 P/Share
|
|
Feb 28
2022
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
189,682
+27.54%
|
$379,364
$2.26 P/Share
|
|
Feb 07
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.94%
|
$98,064
$4.41 P/Share
|
|
Feb 04
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.49%
|
$98,064
$4.41 P/Share
|
|
Feb 03
2022
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
24,516
-6.1%
|
$98,064
$4.59 P/Share
|
|
Jan 20
2022
|
Andrew Dudum Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
1,500
+50.0%
|
$7,500
$5.17 P/Share
|